Avenue Therapeutics Announces Agreement with the FDA on the Study Design and Analysis Approach of the Phase 3 Safety Study for IV Tramadol
MIAMI, July 25, 2023 (GLOBE NEWSWIRE) — Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the…
Month: July 2023
Avenue Therapeutics Announces Agreement with the FDA on the Study Design and Analysis Approach of the Phase 3 Safety Study for IV Tramadol
MIAMI, July 25, 2023 (GLOBE NEWSWIRE) — Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the…
Third Harmonic Bio Announces Next-Generation Oral KIT Inhibitor Product Candidate THB335
THB335 retains selectivity and potency of first-generation oral KIT inhibitor, THB001, with differentiated metabolic, distribution…
Third Harmonic Bio Announces Next-Generation Oral KIT Inhibitor Product Candidate THB335
THB335 retains selectivity and potency of first-generation oral KIT inhibitor, THB001, with differentiated metabolic, distribution…
Neuronetics to Report Second Quarter 2023 Financial and Operating Results and Host Conference Call
MALVERN, Pa., July 25, 2023 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM), a commercial stage…
Neuronetics to Report Second Quarter 2023 Financial and Operating Results and Host Conference Call
MALVERN, Pa., July 25, 2023 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM), a commercial stage…
Patrick J. McEnany Announces Intention to Retire as CEO of Catalyst Pharmaceuticals by Year-End
Mr. McEnany will Continue to Serve as Catalyst’s Non-Executive Chairman of the Board Following his…
Patrick J. McEnany Announces Intention to Retire as CEO of Catalyst Pharmaceuticals by Year-End
Mr. McEnany will Continue to Serve as Catalyst’s Non-Executive Chairman of the Board Following his…
MoonLake completes patient randomization ahead of schedule for its Phase 2 trial in active psoriatic arthritis (PsA) and provides calendar of next readouts
MoonLake completes patient randomization ahead of schedule for its Phase 2 trial in active psoriatic…
MoonLake completes patient randomization ahead of schedule for its Phase 2 trial in active psoriatic arthritis (PsA) and provides calendar of next readouts
MoonLake completes patient randomization ahead of schedule for its Phase 2 trial in active psoriatic…
BioAtla to Announce Second Quarter 2023 Financial Results and Provide Business Highlights on August 1, 2023
SAN DIEGO, July 25, 2023 (GLOBE NEWSWIRE) — BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage…
BioAtla to Announce Second Quarter 2023 Financial Results and Provide Business Highlights on August 1, 2023
SAN DIEGO, July 25, 2023 (GLOBE NEWSWIRE) — BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage…
InspireMD to Report Second Quarter 2023 Financial Results and Provide Corporate Business Update on Tuesday, August 8th
-Conference call and webcast to be held at 8:30 a.m. EDT- TEL AVIV, Israel and…
InspireMD to Report Second Quarter 2023 Financial Results and Provide Corporate Business Update on Tuesday, August 8th
-Conference call and webcast to be held at 8:30 a.m. EDT- TEL AVIV, Israel and…
gammaCore (Non-Invasive Vagus Nerve Stimulation; nVNS) Improves Attention and Memory in Patients with Posttraumatic Stress Disorder (PTSD)
ROCKAWAY, N.J., July 25, 2023 (GLOBE NEWSWIRE) — electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine…
gammaCore (Non-Invasive Vagus Nerve Stimulation; nVNS) Improves Attention and Memory in Patients with Posttraumatic Stress Disorder (PTSD)
ROCKAWAY, N.J., July 25, 2023 (GLOBE NEWSWIRE) — electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine…
Spectral Medical Announces Tigris Clinical Trial Update
Enrollment momentum continues as Tigris Trial reaches 69 patients TORONTO, July 25, 2023 (GLOBE NEWSWIRE)…
Spectral Medical Announces Tigris Clinical Trial Update
Enrollment momentum continues as Tigris Trial reaches 69 patients TORONTO, July 25, 2023 (GLOBE NEWSWIRE)…
Orlando International Airport deploys Tellabs Optical LAN for high-speed, future-proof, energy-saving gains
Orlando International Airport is one of the first airports to install 10 gigabit Passive Optical…
Orlando International Airport deploys Tellabs Optical LAN for high-speed, future-proof, energy-saving gains
Orlando International Airport is one of the first airports to install 10 gigabit Passive Optical…